Physician profile
Yvette Klein
NPI 1285716258
$1,809.28
in general payments reported to CMS, 2019-2025
23 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $155 · 2021: $364 · 2022: $276 · 2023: $282 · 2024: $273 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $506.91 | 2019-2025 | |
| Hologic Sales and Service, LLC | $251.95 | 2019-2025 | Aptima, Affirm Prone Biopsy System, Third Wave |
| Evofem Biosciences, INC. | $138.86 | 2021-2025 | Phexxi, Solosec, Phexx |
| Therapeuticsmd, INC. | $92.08 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $91.18 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.17 | 2019-2023 | |
| Agile Therapeutics, INC. | $89.90 | 2023-2024 | Twirla |
| Pfizer INC. | $79.09 | 2020-2025 | |
| Exact Sciences Corporation | $65.62 | 2023 | Cologuard Collection Kit |
| Exeltis, USA INC. | $62.12 | 2024 | Slynd |
| Avion Pharmaceuticals | $51.86 | 2021-2023 | Balcoltra |
| Viiv Healthcare Company | $50.72 | 2025 | Apretude |
| Optumhealth Care Solutions, LLC | $38.53 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Millicent US INC | $35.75 | 2025 | Intrarosa, Femring, Femlyv |
| Astellas Pharma US INC | $32.82 | 2025 | Veozah |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $24.58 | 2022 | |
| Innovation Technologies INC | $17.77 | 2025 | Irrisept |
| Lupin INC. | $15.65 | 2021 | |
| Shield Therapeutics INC | $15.62 | 2022 | |
| Genentech USA, INC. | $15.07 | 2019 | |
| Allergan, INC. | $14.75 | 2019 | |
| Coopersurgical, INC. | $13.76 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvette Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.